Publications by authors named "Stephan Duparc"

Claim this Profile
T
The non-artemisinin antimalarial drugs under development: a review.
Dearie Glory Okwu, Rella Zoleko Manego, Stephan Duparc, Peter Gottfried Kremsner, Michael Ramharter

Clin Microbiol Infect· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective observational study to assess the feasibility and safety of appropriate radical cure with tafenoquine or primaquine after quantitative G6PD testing during pilot implementation in Thailand.
Prayuth Sudathip, Nardlada Khantikul, Aungkana Saejeng, Stephan Duparc, Penny Grewal Daumerie

BMJ Glob Health· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.
Nada Abla, Anne Claire Marrast, Elodie Jambert, Naomi Richardson, Stephan Duparc

Malar J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
Marcelo Brito, Rosilene Rufatto, José Diego Brito-Sousa, Felipe Murta, Vanderson Sampaio, Stephan Duparc

Lancet Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the next generation of severe malaria treatment: a target product profile.
Jane Achan, Aïssata Barry, Didier Leroy, George Kamara, Stephan Duparc

Malar J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Raman Sharma, Hema Sharma, Siôn Jones, Isabelle Borghini-Fuhrer, Gonzalo J Domingo, Stephan Duparc

Malar J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
Marcelo Brito, Rosilene Rufatto, Felipe Murta, Vanderson Sampaio, Patrícia Balieiro, Stephan Duparc

Lancet Glob Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study.
Michael Ramharter, Abdoulaye A Djimde, Isabelle Borghini-Fuhrer, Robert Miller, Jangsik Shin, Stephan Duparc

Malar J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries.
Mirjam Groger, Gaston Tona Lutete, Serge-Brice Assi, Jude D Bigoga, Nsengi Y Ntamabyaliro, Stephan Duparc

Int J Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Inge Sutanto, Amin Soebandrio, Lenny L Ekawati, Krisin Chand, Rintis Noviyanti, Stephan Duparc

Lancet Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study.
Sagar S Bachhav, Maxine Taylor, Ana Martin, Justin A Green, Stephan Duparc

Br J Clin Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.
Myriam Drysdale, Lionel Tan, Ana Martin, Isabelle Borghini Fuhrer, Stephan Duparc

Infect Dis Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria.
Rezika Mohammed, Mezgebu Silamsaw Asres, Esayas Kebede Gudina, Wondimagegn Adissu, Hilary Johnstone, Stephan Duparc

Am J Trop Med Hyg· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.
Adama Gansane, Moussa Lingani, Adoke Yeka, Alain Nahum, Marielle Bouyou-Akotet, Stephan Duparc

Malar J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.
Nomathemba Chandiwana, Chelsea Kruger, Hilary Johnstone, Mohamed Farouk Chughlay, Chung Ju, Stephan Duparc

EBioMedicine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial.
Mirjam Groger, Gaston Tona Lutete, Ghyslain Mombo-Ngoma, Nsengi Y Ntamabyaliro, Gauthier Kahunu Mesia, Stephan Duparc

Lancet Microbe· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the malaria comprehensive case management programme in Odisha, India.
Madan M Pradhan, Sreya Pradhan, Ambarish Dutta, Naman K Shah, Neena Valecha, Stephan Duparc

PLoS One· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Iván D Vélez, Tran T Hien, Justin A Green, Ana Martin, Hema Sharma, Stephan Duparc

Lancet Child Adolesc Health· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial.
Edgard D Dabira, Sebastian Hachizovu, Bakary Conteh, Alieu Mendy, Haddy Nyang, Stephan Duparc

Clin Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India.
Anupkumar R Anvikar, Prajyoti Sahu, Madan M Pradhan, Supriya Sharma, Naseem Ahmed, Stephan Duparc

Am J Trop Med Hyg· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
Gaston Tona Lutete, Ghyslain Mombo-Ngoma, Serge-Brice Assi, Jude D Bigoga, Felix Koukouikila-Koussounda, Stephan Duparc

PLoS Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.
Nicolas Vignier, Olivier Bouchaud, Andrea Angheben, Emmanuel Bottieau, Guido Calleri, Stephan Duparc

Malar J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.
Pamela L St Jean, Gavin C K W Koh, John J Breton, Fe E J Espino, Tran T Hien, Stephan Duparc

Pharmacogenet Genomics· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated and Malaria in Myanmar.
Kay Thwe Han, Khin Lin, Zay Yar Han, Moe Kyaw Myint, Kyin Hla Aye, Stephan Duparc

Am J Trop Med Hyg· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review.
Stephan Duparc, Stephan Chalon, Scott Miller, Naomi Richardson, Stephen Toovey

Malar J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis